| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773844 | Kidney International Reports | 2018 | 11 Pages |
Abstract
Both PAR and CAL reduced iPTH, but PAR was associated with a higher proportion of patients with iPTHÂ <70 pg/ml. These results do not support the use of PAR to treat posttransplantation hyperparathyroidism.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Josep M. Cruzado, Ricardo Lauzurica, Julio Pascual, Roberto Marcen, Francesc Moreso, Alex Gutierrez-Dalmau, Amado Andrés, Domingo Hernández, Armando Torres, Maria Isabel Beneyto, Edoardo Melilli, Anna Manonelles, Manuel Arias, Manuel Praga,